We are looking for children and teenagers 2–17 years of age to join a trial to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or IBD (including associated symptoms such as abdominal pain, iron deficiency, abdominal pain, chronic fatigue and/or joint pain), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing inflammatory bowel disease flare-ups? Local CD trial is testing a potential new medication to see if it may reduce swollen joints, perianal fistula, abdominal pain, chronic fatigue, and/or joint pain associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the CD trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children at least 2 years of age but under 18 to join a Crohn’s disease medical research study to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or moderate to severe IBD (including associated symptoms such as cramping, weight loss, abdominal pain, chronic fatigue and/or joint pain), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local research is testing a potential new medication to see if it may reduce painful joints, abdominal cramps, bloody stool, frequent fevers, and/or joint pain associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for children to join a clinical research study to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or moderate to severe CD (including associated symptoms such as chronic diarrhea, growth failure, constant need to poop, frequent fevers and/or canker sores), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing CD flare-ups? Local Crohn’s disease (CD) clinical research is testing a potential new medication to see if it may reduce weight loss, failure to thrive, rectal pain, frequent fevers, and/or joint pain associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the Crohn’s disease (CD) clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for children aged 2 to 17 years to join a clinical research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or ulcerative colitis (UC) (including associated symptoms such as abdominal pain, abdominal cramps, constant need to poop, chronic fatigue and/or liver disease), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local Crohn’s disease medical research study is testing a potential new medication to see if it may reduce cramps, fatigue, constant need to poop, weight loss, and/or liver disease associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the Crohn’s disease medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for young people at least 2 years of age but under 18 to join a Crohn’s disease research to help us discover more about treating Crohn’s. If you are looking for a potential new treatment option for Crohn’s or moderate to severe IBD (including associated symptoms such as cramping, weight loss, bloody stool, malnutrition and/or joint pain), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local CD study is testing a potential new medication to see if it may reduce swollen joints, reduced appetite, rectal pain, chronic fatigue, and/or canker sores associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the CD study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.